Filing Details

Accession Number:
0001214659-22-000470
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-07 20:26:45
Reporting Period:
2022-01-07
Accepted Time:
2022-01-07 20:26:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576263 Mirati Therapeutics Inc. MRTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405637 S Vickie Reed C/O Mirati Therapeutics
3545 Cray Court
San Diego CA 92121
Svp, Chief Accounting Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-01-07 345 $135.94 10,525 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 6, 2020.
  2. The price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $135.94 to $136.595, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.